Gland Pharma, after touching its 100-week EMA, is showing signs of recovery. A break above Rs 1,892 could propel the stock towards Rs 2,200, and potentially even Rs 2,500. The stock has formed a double bottom pattern and bounced off the Ichimoku Cloud, with the Supertrend indicator signaling a buy.
